Lobe Sciences Ltd (OTCMKTS:GTSIF) Stock Soars 45% After Preclinical Research Studies Data

September 29, 2021

The publication of interim data with regards to any product or treatment can often lead to a big move in a biotech company’s stock price and that is what happened with the Lobe Sciences Ltd (OTCMKTS:GTSIF) stock on Tuesday. Yesterday the company was in sharp focus after it announced the interim data from the preclinical studies that had been conducted for the treatment of PTSD (post traumatic stress disorder) and…